Biosig Technologies Receivables

Biosig Technologies (BSGM) currently reports a receivables of $54K as of June 2026. That compares with $29K in the prior-year period — up 86.2% year over year. Use the charts on this page to explore Biosig Technologies's receivables history and peer comparisons.

Biosig Technologies's receivables increased from $29K to $54K — a 86.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biosig Technologies reported $54K in receivables as of June 2026. That compares with $29K in the prior-year period — up 86.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $54K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biosig Technologies, and consider following BSGM for alerts when major investors trade the stock.

Biosig Technologies is classified in the Healthcare sector. On receivables, it currently shows $54K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BSGM with unrelated industries.